Design Therapeutics, Inc. (DSGN)
NASDAQ: DSGN · Real-Time Price · USD
15.64
+0.98 (6.68%)
At close: Jul 2, 2026, 4:00 PM EDT
15.96
+0.32 (2.02%)
After-hours: Jul 2, 2026, 7:17 PM EDT
Design Therapeutics Market Cap
Design Therapeutics has a market cap or net worth of $976.83 million as of July 2, 2026. Its market cap has increased by 367.59% in one year.
Market Cap
976.83M
Enterprise Value
756.74M
1-Year Change
367.59%
Ranking
Category
Stock Price
$15.64
Market Cap Chart
Since the IPO on March 26, 2021, Design Therapeutics's market cap has decreased from $2.21B to $976.83M, a decrease of -55.72%. That is a compound annual growth rate of -14.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2026 | 976.83M | 82.82% |
| Dec 31, 2025 | 534.32M | 52.95% |
| Dec 31, 2024 | 349.35M | 135.41% |
| Dec 29, 2023 | 148.40M | -74.10% |
| Dec 30, 2022 | 572.92M | -51.55% |
| Dec 31, 2021 | 1.18B | -46.40% |
| Mar 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lexicon Pharmaceuticals | 1.03B |
| Pharming Group | 991.68M |
| Avalo Therapeutics | 990.34M |
| Kura Oncology | 985.40M |
| DBV Technologies | 979.61M |
| Replimune Group | 972.08M |
| SL Science Holding | 968.13M |
| Arbutus Biopharma | 962.01M |